Rou, W.S.; Eun, H.S.; Choung, S.; Jeon, H.J.; Joo, J.S.; Kang, S.H.; Lee, E.S.; Kim, S.H.; Kwon, I.S.; Ku, B.J.;
et al. Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma. Cancers 2023, 15, 2634.
https://doi.org/10.3390/cancers15092634
AMA Style
Rou WS, Eun HS, Choung S, Jeon HJ, Joo JS, Kang SH, Lee ES, Kim SH, Kwon IS, Ku BJ,
et al. Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma. Cancers. 2023; 15(9):2634.
https://doi.org/10.3390/cancers15092634
Chicago/Turabian Style
Rou, Woo Sun, Hyuk Soo Eun, Sorim Choung, Hong Jae Jeon, Jong Seok Joo, Sun Hyung Kang, Eaum Seok Lee, Seok Hyun Kim, In Sun Kwon, Bon Jeong Ku,
and et al. 2023. "Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma" Cancers 15, no. 9: 2634.
https://doi.org/10.3390/cancers15092634
APA Style
Rou, W. S., Eun, H. S., Choung, S., Jeon, H. J., Joo, J. S., Kang, S. H., Lee, E. S., Kim, S. H., Kwon, I. S., Ku, B. J., & Lee, B. S.
(2023). Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma. Cancers, 15(9), 2634.
https://doi.org/10.3390/cancers15092634
